**Cephalosporins withPseudomonas AeruginosaCoverage**

Felicilda Reynaldo, Rhea Faye D.
Inocian, Ergie P.
Patterson, Kathryn
Adams, Kathryn

Rhea Faye D. Felicilda Reynaldo, EdD, RN, is Adjunct Faculty, Missouri State University, Springfield, MO; and Adjunct Faculty, Post University: American Sentinel College of Nursing and Health Sciences, Denver, CO.
Ergie P. Inocian, EdD, RN, CNOR, is Clinical Assistant Professor, School of Nursing, Duquesne University, Pittsburgh, PA.
Kathryn Patterson, DNP, FNP-BC, is Clinical Associate Professor, School of Nursing, Missouri State University, Springfield, MO.
Kathryn Adams, DNP, RN-BC, is Clinical Assistant Professor, School of Nursing, Missouri State University, Springfield, MO.

MEDSURG Nursing 30(4):p 270-274, July-August 2021.

P. aeruginosa infection is a serious condition that requires prompt attention and pertinent clinical decisions. Early administration of appropriate antibiotics, optimal dosing, and appropriate interval of drug administration and duration of therapy are key factors influencing clinical outcomes by maximizing the likelihood of achieving therapeutic concentrations.